Best F.I.P Treatments for Cats | GS-441524 & Molnupiravir Options

GS-441524 is an antiviral compound that targets and inhibits the replication of the feline coronavirus responsible for FIP. It works by interfering with the virus's RNA synthesis, ultimately helping to reduce the viral load in affected cats. It has shown high success rates, particularly for non-neurological cases.

Molnupiravir is an antiviral initially developed for human use, which has shown promise as an off-label treatment for FIP in cats. While research is still ongoing, anecdotal and emerging clinical evidence supports its effectiveness, especially for neurological and ocular FIP cases. However, it's important to use it under veterinary guidance.

Treatment typically lasts around 84 days (12 weeks) for both medications, though the exact duration can vary based on the cat’s response, the severity of the disease, and whether neurological symptoms are present. Bloodwork and clinical signs are monitored throughout to assess progress.

GS-441524 is generally well-tolerated but may cause pain or swelling at injection sites. Molnupiravir, taken orally, may lead to mild gastrointestinal upset in some cats. In rare cases, more serious side effects have been reported, so regular vet monitoring is essential.

Yes, many cats treated with GS-441524 or Molnupiravir have gone into full remission, especially when treatment starts early. Success rates for GS-441524 exceed 80%, and while Molnupiravir data is more limited, it has shown comparable outcomes in appropriate cases.

Yes - your Veterinarian may order from us directly, or they can write you a prescription for GS-441524 and / or Molnupiravir.

It is generally not recommended to use both simultaneously unless specifically advised by a veterinarian with experience in FIP treatment. These antivirals work through different mechanisms, and combining them could lead to unknown interactions or reduced effectiveness. Sequential use may be considered in certain complex cases under vet supervision.